Since at least the 1960s, researchers have identified poor-urban areas (the ''inner city'') as hotspots of high asthma prevalence and morbidity. 1, 2 Over the past several decades, the National Institutes of Health and other public health institutions have focused substantial resources on inner-city areas, usually defined for official purposes as census tracts in large central metropolitan areas with > _20% of households below the poverty line, in an effort to reduce asthma disparities. However, until recently, there was very little data on the national scale to confirm that inner-city residence is in fact associated with either a higher prevalence of asthma or, among those with asthma, greater asthma morbidity. In a recent analysis of data from the National Health Interview Survey, we recently found that residence in inner-city areas was not actually associated with higher prevalence of asthma in children across the United States. 3 Because the National Health Interview Survey does not include rates of asthma outpatient visits, emergency department (ED) visits, or hospitalizations, we were unable to determine whether living in an inner city was associated with increased morbidity among children with asthma in our previous study. Medicaid, as a federally funded program available to low-income children across the United States with central collation of claims data, offers the ability to assess the effect of residence in poor and urban areas among low-income children nationally. Thus, our goal was first to determine whether living in an inner city is indeed associated with increased morbidity, as assessed by more frequent hospitalizations or ED visits, among low-income children with asthma and if so, whether urbanization, neighborhood poverty, or race/ethnicity were independently associated with asthma morbidity. Children with asthma were defined as those who had > _1 outpatient or ED visit with a primary International Classification of Diseases, Ninth Revision diagnosis code of an asthma-related condition (493.x) over the 2-year period of observation.
For the purposes of asthma morbidity analyses, ED visits were defined as outpatient visits occurring in hospital-based EDs with a primary or secondary diagnosis code of an asthma-related condition. Inpatient visits were defined as those occurring in a hospital with a primary diagnosis code of an asthmarelated condition. Outpatient visits for asthma, excluding hospital-based EDs, with a primary or secondary diagnosis code of an asthma-related condition were analyzed separately.
Urbanization status of each subject was classified on the county level using the National Centers for Health Statistics Urban Rural Codes 2013. 4 This classification system divides counties into large central metro (''urban''), large fringe metro (''suburban''), medium metro, small metro, micropolitan, and noncore. Because there are relatively few people living in small metro, micropolitan, and noncore areas, these categories were collapsed.
Neighborhood poverty was classified at the zip-code tabulation area level by linking participant zip codes to data from the Missouri Data Resource Center.
5 This dataset maps census-level data from the American Community Survey 2008 to 2012 to Zip Code Tabulation Areas. Race/ethnicity was defined as non-Hispanic white, non-Hispanic black, Hispanic or Latino (''Hispanic''), Asian, or ''other,'' which included multiracial (non-Hispanic), American Indian or Alaskan Native, and Native Hawaiian. Residence in an inner city was defined as living in a county defined as Urban and a zip code with > _20% of households below the federally defined poverty line. 6 Procedures for reporting race/ethnicity varied by state, with some states mandating reporting of race/ethnicity, others not reporting race/ethnicity at all, reporting on only a portion of participants, and/or with improbable lack of certain racial/ethnic groups. Because race/ethnicity was unlikely to be reliable in states with high levels of missing or improbable data, and because race/ethnicity was an important covariate and predictor in our analyses, we only included states where < _10% of participants had missing data on race/ethnicity and where all major race/ethnicity groups were represented in the data. This excluded Massachusetts, Rhode Island, Iowa, Washington, Vermont, Colorado, Arkansas, Wisconsin, and New Jersey. Maine did not have clinical information available. The combined eligible population in these 10 states represents about 12% of the total Medicaid Analytic Extract population. In addition, because our primary analysis was a 2-level analysis combining state-level analyses, states without urban areas could not contribute to analyses comparing urban to nonurban areas. This requirement excluded an additional 17 states, leaving Arizona, California, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Michigan, Minnesota, Missouri, North Carolina, New York, Ohio, Oregon, Pennsylvania, Texas, and Virginia. Subjects were included for months in which they were enrolled in Medicaid with unrestricted benefits.
Statistical methods
Because each state has different Medicaid eligibility criteria and may have other sources of heterogeneity in claims data, the analysis was conducted in 2 stages. At the first stage, overdispersed log-linear Poisson regression models (logistic models for binary outcomes) were used to estimate the association between key predictors (eg, urbanization status, race/ethnicity, and neighborhood poverty) and counts of asthma outcomes (hospitalizations, ED visits, outpatient visits) for each state. At this stage, crude and adjusted models were used, where adjusted models included covariates on poverty, urbanization, sex, race, and age. At the second stage, associations (ie, coefficients) between key predictors and outcomes in each state were combined using a 2-level normal hierarchical model. 7 Given the large sample sizes available in this study, each estimated coefficient was assumed to have a normal distribution about its true value. Then, state-specific coefficients were modeled as having a normal distribution around a national average association. The approach uses Bayesian modeling with a normal prior distribution placed on the national average association and a uniform prior placed on the heterogeneity variance. Samples were drawn from the posterior distribution of the national average association, and we report the posterior mean as our estimate. This approach accounts for the statistical uncertainty incurred in the first stage and potential unexplained variability between states at the second stage, similar to a meta-analysis. The resulting CIs and P values incorporate both sources of variability. Potential confounders were included in the state-specific regression models.
RESULTS Demographics
A total of 16,860,716 children who were enrolled in Medicaid between 2009 and 2010 were included, of whom 1,534,820 (8.8%) had > _1visit with a primary diagnosis of asthma (see Table I for demographic information). Among those with asthma, there were a mean of 3.7 outpatient visits, 0.30 ED visits, and 0.02 hospital admissions per person per year (Table II) .
Asthma prevalence
In both crude and adjusted analyses, the prevalence of current asthma was not different in inner-city (poor urban) areas compared with non-inner-city areas (crude odds ratio, 0.99; 95% CI, 0.81-1.22; adjusted odds ratio, 0.95; 95% CI, 0.81-1.12), and urban status was not a predictor of asthma prevalence in analyses adjusting for neighborhood poverty and race/ethnicity. Black race and residence in a poor neighborhood were significant risk factors for prevalent asthma (Table III) .
Asthma morbidity
Inner-city areas. Among children with asthma, living in an inner-city (poor-urban area) was a risk factor for asthma-related ED visits and hospitalizations in crude analyses (risk ratio, 1.39; 95% CI, 1.24-1.57; and 1.62; 95% CI, 1.36-1.93, respectively) and in those adjusted for race/ethnicity, age, and sex, although the effect size was attenuated (risk ratio, 1.14; 95% CI, 1.05-1.26; and 1.30; 95% CI, 1.14-1.47, for ED visits and hospitalizations, respectively) (Fig 1) .
Urban/rural status. Among asthmatics, there were significantly fewer ED visits and hospitalizations among those living in suburban, medium metro, or small/microcore areas compared with urban areas in crude and adjusted analyses. The strongest of these associations were with hospitalizations, where those living in nonurban areas had 18% to 28% lower risk of hospitalizations than those living in urban areas, even after accounting for race/ethnicity (Table IV) .
Poverty. Among this low-income population, residence in poor neighborhoods was associated with more asthma-related ED visits and hospitalizations in crude and adjusted analyses (Table IV) .
Race/ethnicity. Among asthmatics, non-Hispanic black children and children of ''other'' race had significantly higher rates of ED visits and hospitalizations for asthma than did non-Hispanic white children, in crude and adjusted analyses. These relationships were strongest for hospitalization, where even after adjustment, black children had 89% and children of ''other'' race 61% higher risk of asthma-related hospitalizations than non-Hispanic white children did. Hispanic children did not have significantly different rates of ED visits or hospitalizations in adjusted analyses compared with non-Hispanic white children. In contrast, Asian children had significantly fewer ED visits and hospitalizations than non-Hispanic white children did in adjusted analyses (Table IV) .
Interactions between urban/rural status, race/ ethnicity and poverty. Because our previous investigations had shown that relationships between poverty and asthma prevalence differed between Hispanic children and nonHispanic children, we examined whether relationships between neighborhood poverty and asthma morbidity also differed by Hispanic status, and we did not find that this was the case (data not shown). In addition, we also examined whether residence in an urban area affected asthma morbidity differently among Hispanic and non-Hispanic children, and we found that the relationship between asthma morbidity and residence in a small/micro/rural area compared with an urban area was different for Hispanic compared with non-Hispanic children. Specifically, among Hispanic children, residence in a small/micro/rural area was not protective for ED visits or hospitalizations, whereas it was among other racial/ethnic groups ( Table V) .
Fraction of hospitalizations attributable to race/ ethnicity, poverty, and urban residence. The fraction of asthma hospitalizations attributable to race/ethnicity, residence in a poor area, and residence in an urban area were calculated from the fully adjusted model. Among this Medicaid population, 19% of hospitalizations are estimated to be attributable to black race/ ethnicity, 4% to residence in a poor area, and 7% to residence in an urban area. Thus, we estimate that a full 30% of asthma hospitalizations among children on Medicaid could be attributable to socioeconomic, geographic, and racial/ethnic disparities.
Frequency of outpatient visits. To evaluate the possibility that differences found in ED visits and hospitalizations between geographic areas and racial/ethnic groups were due to differences in the propensity to use hospital-based versus non-hospital-based medical services, we also examined associations with rates of outpatient visits separately. We found that with the exception of Asian race/ethnicity, which was associated with more outpatient visits but fewer ED visits and hospitalizations, risk factors for ED visits and hospitalizations showed the same direction of association with outpatient visits, although the magnitude of the relationships were smaller, and less often statistically significant (Table IV) .
DISCUSSION
In this analysis of 1.5 million children with asthma who were enrolled in Medicaid from 2009 to 2010, we found that, among this lower income population, those living in inner-city areas had an overall 40% higher risk of asthma-related ED visits and 62% higher risk of asthma-related hospitalizations than those living in other kinds of neighborhoods, even though overall asthma prevalence was not increased. Although adjustment for race/ethnicity did attenuate this increased risk to a 14% and 30% higher risk of ED visits and hospitalizations, respectively, residence in inner-city areas remained a risk for asthma morbidity even after adjusting for race/ethnicity, age, and sex. By definition, inner-city areas are both poor and urban, and we further found that both of these factors were independent risk factors for asthma morbidity. Together, these findings highlight substantial geographic and racial disparities in asthma morbidity in the United States and support the theory that risk factors concentrated in poor and urban areas contribute to asthma morbidity, even if they may not necessarily contribute to its development.
It is very likely that no one exposure accounts for the increased asthma morbidity associated with living in poor or urban areas. Researchers studying asthma in the inner city have established that exposure to common household pests that are more common in poor and urban areas, such as cockroaches 8 and mice, 9 is associated with worse asthma control. Air pollution, which may act synergistically with allergen exposures, 10 is another likely contributor to increased morbidity in poor and urban areas. 11 Both urban and poor areas tend to have higher densities of major roadways and to be closer to stationary sources of air pollution, such as power plants and manufacturing facilities, and thus have higher levels of pollutants associated with asthma morbidity, such as particulate matter, nitric oxides, and ozone. Additional environmental factors that may contribute to asthma morbidity in poor and urban areas include exposure to secondhand smoke 12 and other sources of indoor pollution, 13 prematurity, 14 and social stress. 15 Differences in health care quality, adherence to medications, and care access patterns could also explain some of the neighborhood disparities found here. 16, 17 Generally, we found that trends with outpatient visits followed those of ED visits and hospitalizations, suggesting that treatment in the non-ED outpatient setting was not responsible for the associations seen. More broadly, however, it is difficult within Medicaid to distinguish increased asthma morbidity due to inadequate use of preventative care from that due to environmental exposures. In contrast to our morbidity findings, here we show that residence in urban areas, or even inner-city areas, is not associated with increased prevalence of asthma, similar to what we previously found in our analysis of the National Health Information Survey. 3 It is becoming increasingly clear that at least some of the factors that contribute to asthma morbidity may be distinct from those that contribute to initiation of asthma. For example, exposure to pest allergens, while strongly associated with asthma morbidity among urban children, 9, 18 was recently shown to protect against development of wheeze and allergic sensitization among high-risk urban infants. 19 Other exposures strongly tied to asthma morbidity may similarly have weaker relationships with asthma inception.
Even after adjusting for neighborhood poverty and urban residence, we found that black race/ethnicity was associated with markedly increased rates of outpatient visits, ED visits, and hospitalizations for asthma, on top of the already increased risk of current asthma. As with urban/rural status and neighborhood poverty, there are likely several reasons for racial/ethnic disparities in asthma morbidity. Genetic differences in risk of asthma development and morbidity have been proposed, and there is some evidence that genes associated with African heritage may be related to asthma. [20] [21] [22] However, it can be difficult to separate ancestry from socioeconomic status, and it is possible that the crude measures of socioeconomic status used here and in other studies may underestimate the contribution of socioeconomic disparities to racial/ethnic asthma disparities. 23 For example, because of the historical legacy of segregation and discrimination in the United States, there are large wealth gaps by race/ethnicity, even among families with the same income, so simply measuring income underestimates socioeconomic disparities by race/ethnicity. 24 Income and urban status may also poorly capture relevant neighborhood factors, such as air pollution and poor housing stock, which are more likely to be experienced by minority families. 25 Whatever the cause, these disparities are striking and remain a serious public health problem.
In our previous analysis of National Health Interview Survey data, 3 we found that among Hispanic children, poverty was protective against prevalent asthma. Here, among low-income children with asthma, we did not find that being of Hispanic race/ethnicity changed the relationship between living in a poor neighborhood and asthma morbidity. However, we did find that for Hispanic children, the relationship between urban residence and asthma morbidity differed compared with other ethnicities, with rural residence conferring no benefit to Hispanic children. We speculate that Hispanic children may be more likely to live in rural areas that have worse air pollution than the rural areas where other race/ethnicities predominate. For example, a high density of Hispanic children live in nonurban areas in the California central valley, an area with among the highest levels of air pollution in the United States. 26 There are several limitations to our analyses. Most importantly, data were collected for administrative purposes, and, as is the case for any analyses that rely on claims data, it is possible that diagnostic miscoding could affect our results. In addition, individual-level income data were not available, and Medicaid data are coded only to the zip code tabulation area, so the assignment of neighborhood poverty was by the zip code, potentially leading to residual confounding by income. However, children enrolled in Medicaid are all low income, and we accounted for neighborhood income, so we would expect residual confounding by income to be minimal. Outpatient visits could have included follow-up visits for asthma care and so may not fully represent asthma morbidity. However, this limitation should not apply to ED visits and hospitalizations. State rules for Medicaid eligibility vary by state, so there may be some heterogeneity between states, but we accounted for this in our statistical methods. We only included states with race/ethnicity data and with > _1 urban area, potentially limiting the generalizability of our data. The available data did not allow us to separate our subgroups of Hispanic children, such as Puerto Rican and Mexican children, who have been reported to have different asthma prevalence and morbidity. Finally, while Medicaid provides an opportunity to disentangle risk factors among those that are most disadvantaged and have the highest burden of asthma, the results may not be generalizable to all socioeconomic groups.
These limitations are balanced by several important strengths. Most importantly, this is a massive database that includes data on >1.5 million children with asthma, allowing us to make conclusions about low-income children across the entire United States, instead of just limiting our analysis to 1 city or region. In addition, our analysis strategy minimized the effect of between-state differences, as we analyzed each state individually and combined the analyses for our final estimates.
In conclusion, in this comprehensive analysis of children with asthma covered by Medicaid, we found significant disparities in asthma morbidity related to race/ethnicity and residence in poor and urban neighborhoods. These findings support the theory that environmental risk factors for asthma exacerbation are concentrated in poor urban areas, but highlight the fact that despite several decades of attention to asthma in the inner city, asthma morbidity remains high in urban and poor areas.
Key message
d Residence in an urban or poor area and black race/ ethnicity are each significant independent risk factors for asthma ED visits and hospitalizations among US children who are enrolled in Medicaid.
